+499.5%
MRNA vs CCJ
+31.2%
+468.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CCJ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.1% | -2.3% | -2.3% |
| 7D | +5.5% | +0.7% | +4.7% | +5.0% |
| 30D | +158.7% | +6.9% | +151.9% | +155.4% |
| 3M | +182.1% | -11.6% | +193.8% | +188.1% |
| 6M | +151.8% | -16.2% | +168.0% | +157.1% |
| YTD | +393.6% | +10.1% | +383.4% | +406.2% |
| 1Y | +499.5% | +32.3% | +467.2% | +541.2% |
| All | +499.5% | +31.2% | +468.3% | +541.2% |
Cumulative growth
Daily Returns
Daily percentage return beside CCJ.
Daily Out/Under-Performance
Portfolio return minus CCJ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CCJ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CCJ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling